Global Lower GI Series Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

August 2018 | 124 pages | ID: G552D4821F9GEN
GlobalInfoResearch

Abstracts

A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.

SCOPE OF THE REPORT:

This report studies the Lower GI Series market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lower GI Series market by product type and applications/end industries.
A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.
The global Lower GI Series market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lower GI Series.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

• Eisai
• Cadila Pharmaceuticals
• Purdue Pharma
• Peacehealth
• Novadaq
• Astrazeneca
• Ironwood Pharmaceuticals

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Double-Contrast
• Single-Contrast

Market Segment by Applications, can be divided into

• Gastroenteritis
• Colon Polyps
• Tumor
• Strictures Crohn's Disease
• Ulcerative Colitis
• Others

Contents

1 LOWER GI SERIES MARKET OVERVIEW

1.1 Product Overview and Scope of Lower GI Series
1.2 Classification of Lower GI Series by Types
  1.2.1 Global Lower GI Series Revenue Comparison by Types (2017-2023)
  1.2.2 Global Lower GI Series Revenue Market Share by Types in 2017
  1.2.3 Double-Contrast
  1.2.4 Single-Contrast
1.3 Global Lower GI Series Market by Application
  1.3.1 Global Lower GI Series Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Gastroenteritis
  1.3.3 Colon Polyps
  1.3.4 Tumor
  1.3.5 Strictures Crohn's Disease
  1.3.6 Ulcerative Colitis
  1.3.7 Others
1.4 Global Lower GI Series Market by Regions
  1.4.1 Global Lower GI Series Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Lower GI Series Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Lower GI Series Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lower GI Series Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Lower GI Series Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lower GI Series Status and Prospect (2013-2023)
1.5 Global Market Size of Lower GI Series (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Eisai
  2.1.1 Business Overview
  2.1.2 Lower GI Series Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Eisai Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cadila Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Lower GI Series Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Cadila Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.3 Purdue Pharma
  2.3.1 Business Overview
  2.3.2 Lower GI Series Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Purdue Pharma Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.4 Peacehealth
  2.4.1 Business Overview
  2.4.2 Lower GI Series Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Peacehealth Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novadaq
  2.5.1 Business Overview
  2.5.2 Lower GI Series Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Novadaq Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astrazeneca
  2.6.1 Business Overview
  2.6.2 Lower GI Series Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Astrazeneca Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ironwood Pharmaceuticals
  2.7.1 Business Overview
  2.7.2 Lower GI Series Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Ironwood Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL LOWER GI SERIES MARKET COMPETITION, BY PLAYERS

3.1 Global Lower GI Series Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Lower GI Series Players Market Share
  3.2.2 Top 10 Lower GI Series Players Market Share
3.3 Market Competition Trend

4 GLOBAL LOWER GI SERIES MARKET SIZE BY REGIONS

4.1 Global Lower GI Series Revenue and Market Share by Regions
4.2 North America Lower GI Series Revenue and Growth Rate (2013-2018)
4.3 Europe Lower GI Series Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lower GI Series Revenue and Growth Rate (2013-2018)
4.5 South America Lower GI Series Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lower GI Series Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA LOWER GI SERIES REVENUE BY COUNTRIES

5.1 North America Lower GI Series Revenue by Countries (2013-2018)
5.2 USA Lower GI Series Revenue and Growth Rate (2013-2018)
5.3 Canada Lower GI Series Revenue and Growth Rate (2013-2018)
5.4 Mexico Lower GI Series Revenue and Growth Rate (2013-2018)

6 EUROPE LOWER GI SERIES REVENUE BY COUNTRIES

6.1 Europe Lower GI Series Revenue by Countries (2013-2018)
6.2 Germany Lower GI Series Revenue and Growth Rate (2013-2018)
6.3 UK Lower GI Series Revenue and Growth Rate (2013-2018)
6.4 France Lower GI Series Revenue and Growth Rate (2013-2018)
6.5 Russia Lower GI Series Revenue and Growth Rate (2013-2018)
6.6 Italy Lower GI Series Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC LOWER GI SERIES REVENUE BY COUNTRIES

7.1 Asia-Pacific Lower GI Series Revenue by Countries (2013-2018)
7.2 China Lower GI Series Revenue and Growth Rate (2013-2018)
7.3 Japan Lower GI Series Revenue and Growth Rate (2013-2018)
7.4 Korea Lower GI Series Revenue and Growth Rate (2013-2018)
7.5 India Lower GI Series Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lower GI Series Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA LOWER GI SERIES REVENUE BY COUNTRIES

8.1 South America Lower GI Series Revenue by Countries (2013-2018)
8.2 Brazil Lower GI Series Revenue and Growth Rate (2013-2018)
8.3 Argentina Lower GI Series Revenue and Growth Rate (2013-2018)
8.4 Colombia Lower GI Series Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE LOWER GI SERIES BY COUNTRIES

9.1 Middle East and Africa Lower GI Series Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lower GI Series Revenue and Growth Rate (2013-2018)
9.3 UAE Lower GI Series Revenue and Growth Rate (2013-2018)
9.4 Egypt Lower GI Series Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lower GI Series Revenue and Growth Rate (2013-2018)
9.6 South Africa Lower GI Series Revenue and Growth Rate (2013-2018)

10 GLOBAL LOWER GI SERIES MARKET SEGMENT BY TYPE

10.1 Global Lower GI Series Revenue and Market Share by Type (2013-2018)
10.2 Global Lower GI Series Market Forecast by Type (2018-2023)
10.3 Double-Contrast Revenue Growth Rate (2013-2023)
10.4 Single-Contrast Revenue Growth Rate (2013-2023)

11 GLOBAL LOWER GI SERIES MARKET SEGMENT BY APPLICATION

11.1 Global Lower GI Series Revenue Market Share by Application (2013-2018)
11.2 Lower GI Series Market Forecast by Application (2018-2023)
11.3 Gastroenteritis Revenue Growth (2013-2018)
11.4 Colon Polyps Revenue Growth (2013-2018)
11.5 Tumor Revenue Growth (2013-2018)
11.6 Strictures Crohn's Disease Revenue Growth (2013-2018)
11.7 Ulcerative Colitis Revenue Growth (2013-2018)
11.8 Others Revenue Growth (2013-2018)

12 GLOBAL LOWER GI SERIES MARKET SIZE FORECAST (2018-2023)

12.1 Global Lower GI Series Market Size Forecast (2018-2023)
12.2 Global Lower GI Series Market Forecast by Regions (2018-2023)
12.3 North America Lower GI Series Revenue Market Forecast (2018-2023)
12.4 Europe Lower GI Series Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lower GI Series Revenue Market Forecast (2018-2023)
12.6 South America Lower GI Series Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lower GI Series Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Lower GI Series Picture
Table Product Specifications of Lower GI Series
Table Global Lower GI Series and Revenue (Million USD) Market Split by Product Type
Figure Global Lower GI Series Revenue Market Share by Types in 2017
Figure Double-Contrast Picture
Figure Single-Contrast Picture
Table Global Lower GI Series Revenue (Million USD) by Application (2013-2023)
Figure Lower GI Series Revenue Market Share by Applications in 2017
Figure Gastroenteritis Picture
Figure Colon Polyps Picture
Figure Tumor Picture
Figure Strictures Crohn's Disease Picture
Figure Ulcerative Colitis Picture
Figure Others Picture
Table Global Market Lower GI Series Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Lower GI Series Revenue (Million USD) and Growth Rate (2013-2023)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Lower GI Series Type and Applications
Table Eisai Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cadila Pharmaceuticals Lower GI Series Type and Applications
Table Cadila Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table Purdue Pharma Lower GI Series Type and Applications
Table Purdue Pharma Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Peacehealth Basic Information, Manufacturing Base and Competitors
Table Peacehealth Lower GI Series Type and Applications
Table Peacehealth Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Novadaq Basic Information, Manufacturing Base and Competitors
Table Novadaq Lower GI Series Type and Applications
Table Novadaq Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Astrazeneca Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Lower GI Series Type and Applications
Table Astrazeneca Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ironwood Pharmaceuticals Lower GI Series Type and Applications
Table Ironwood Pharmaceuticals Lower GI Series Revenue, Gross Margin and Market Share (2016-2017)
Table Global Lower GI Series Revenue (Million USD) by Players (2013-2018)
Table Global Lower GI Series Revenue Share by Players (2013-2018)
Figure Global Lower GI Series Revenue Share by Players in 2016
Figure Global Lower GI Series Revenue Share by Players in 2017
Figure Global Top 5 Players Lower GI Series Revenue Market Share in 2017
Figure Global Top 10 Players Lower GI Series Revenue Market Share in 2017
Figure Global Lower GI Series Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Lower GI Series Revenue (Million USD) by Regions (2013-2018)
Table Global Lower GI Series Revenue Market Share by Regions (2013-2018)
Figure Global Lower GI Series Revenue Market Share by Regions (2013-2018)
Figure Global Lower GI Series Revenue Market Share by Regions in 2017
Figure North America Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Europe Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Lower GI Series Revenue and Growth Rate (2013-2018)
Figure South America Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Lower GI Series Revenue and Growth Rate (2013-2018)
Table North America Lower GI Series Revenue by Countries (2013-2018)
Table North America Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure North America Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure North America Lower GI Series Revenue Market Share by Countries in 2017
Figure USA Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Canada Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Mexico Lower GI Series Revenue and Growth Rate (2013-2018)
Table Europe Lower GI Series Revenue (Million USD) by Countries (2013-2018)
Figure Europe Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure Europe Lower GI Series Revenue Market Share by Countries in 2017
Figure Germany Lower GI Series Revenue and Growth Rate (2013-2018)
Figure UK Lower GI Series Revenue and Growth Rate (2013-2018)
Figure France Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Russia Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Italy Lower GI Series Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Lower GI Series Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Lower GI Series Revenue Market Share by Countries in 2017
Figure China Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Japan Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Korea Lower GI Series Revenue and Growth Rate (2013-2018)
Figure India Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Lower GI Series Revenue and Growth Rate (2013-2018)
Table South America Lower GI Series Revenue by Countries (2013-2018)
Table South America Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure South America Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure South America Lower GI Series Revenue Market Share by Countries in 2017
Figure Brazil Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Argentina Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Colombia Lower GI Series Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Lower GI Series Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lower GI Series Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Lower GI Series Revenue Market Share by Countries in 2017
Figure Saudi Arabia Lower GI Series Revenue and Growth Rate (2013-2018)
Figure UAE Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Egypt Lower GI Series Revenue and Growth Rate (2013-2018)
Figure Nigeria Lower GI Series Revenue and Growth Rate (2013-2018)
Figure South Africa Lower GI Series Revenue and Growth Rate (2013-2018)
Table Global Lower GI Series Revenue (Million USD) by Type (2013-2018)
Table Global Lower GI Series Revenue Share by Type (2013-2018)
Figure Global Lower GI Series Revenue Share by Type (2013-2018)
Figure Global Lower GI Series Revenue Share by Type in 2017
Table Global Lower GI Series Revenue Forecast by Type (2018-2023)
Figure Global Lower GI Series Market Share Forecast by Type (2018-2023)
Figure Global Double-Contrast Revenue Growth Rate (2013-2018)
Figure Global Single-Contrast Revenue Growth Rate (2013-2018)
Table Global Lower GI Series Revenue by Application (2013-2018)
Table Global Lower GI Series Revenue Share by Application (2013-2018)
Figure Global Lower GI Series Revenue Share by Application (2013-2018)
Figure Global Lower GI Series Revenue Share by Application in 2017
Table Global Lower GI Series Revenue Forecast by Application (2018-2023)
Figure Global Lower GI Series Market Share Forecast by Application (2018-2023)
Figure Global Gastroenteritis Revenue Growth Rate (2013-2018)
Figure Global Colon Polyps Revenue Growth Rate (2013-2018)
Figure Global Tumor Revenue Growth Rate (2013-2018)
Figure Global Strictures Crohn's Disease Revenue Growth Rate (2013-2018)
Figure Global Ulcerative Colitis Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Lower GI Series Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Lower GI Series Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Lower GI Series Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Lower GI Series Revenue Market Forecast (2018-2023)
Figure Europe Lower GI Series Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Lower GI Series Revenue Market Forecast (2018-2023)
Figure South America Lower GI Series Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Lower GI Series Revenue Market Forecast (2018-2023)